January 21, 2021

The Niche

Trusted stem cell blog & resources

Alan Trounson

4 min read

By Heather Main What countries are doing disproportionately well given their size on their stem cell research? When reading through the ISSCR 2015 program you can understand why everyone wants to go to the US for their postdoc as it seems like most of the work being presented is US-based. In fact, this is more than true with 78 of 156 speakers being USA based, a straight 50% of the program. Coming in second is Germany with 11 speakers. Being an Aussie I wanted …Read More

5 min read

By Jeanne Loring As the California Institute for Regenerative Medicine (CIRM) celebrates its successes on its 10th anniversary, there is coincidentally a less happy CIRM-related event. One of CIRM’s first investments in stem cell research was a network of dedicated stem cell laboratories throughout California. This program, called “shared labs” has been cancelled. The shared lab idea originated as a means for California researchers to work on human embryonic stem cells without compromising their funding from the NIH. CIRM invested a million dollars for …Read More

2 min read

StemCells, Inc. is one of those stem cell-related biotech companies that we in the field hope will become a big success and help many patients in the future via stem cell technology. There are a lot of obstacles facing such companies. Some are privately held, while others such as StemCells, Inc. are publicly traded (stock symbol STEM). Unfortunately, StemCells, Inc. has had to face two rather serious problems in the last few weeks. First, former CIRM President Alan Trounson joined the leadership of StemCells, Inc. only days …Read More

2 min read

The future is now. Or so goes the expression. For CIRM, it rings true today. Last year I blogged about what we might expect from the new CIRM that would evolve and take form in the future. I was particularly thinking about this coming incarnation of CIRM, which I called CIRM 2.0, as it related to post-2017 when existing Prop. 71 state funding will run out and I was making the case for additional state funding for beyond 2017 for CIRM. However, the stem …Read More

2 min read

CIRM, the California Stem Cell Agency, is looking for a new President since current President Alan Trounson announced that he will be moving on at some point in the near future. CIRM itself is undergoing changes as it anticipates a key turning point in 2017 when it will not have state funding from Prop 71 any longer barring some new development. I posted before about the results of a very informal survey of stem cell bigwigs about who they were thinking about as possible …Read More

1 min read

The current President of the California Institute for Regenerative Medicine (CIRM), Dr. Alan Trounson, will be leaving the agency in the near future to have more time with his family back in Australia. As a result, CIRM will need a new President at a critical juncture in its history with only about 4 years of funding left. This new leader ideally will guide CIRM not only in the present but also during its transition to become whatever its identity will be in 2017 and …Read More

3 min read

Five legends and a blogger walk into a bar together. The bartender asks the first legend “What can I get for you?” The legend orders their drink. The bartender eventually serves up drinks to all five legends and turns to the blogger, “And what can I get for you?” The blogger replies, “Do you have Wi-Fi? “…..and a beer.” I’ve now been doing my stem cell blog for about 2 1/2 years. It started as an experiment and sort of took on a life of …Read More